United States Dialysis Market Size & Forecast 2025–2033

United States Dialysis Market Overview

According to Renub Research Latest Report United States dialysis market is projected to grow from US$ 1.35 billion in 2024 to US$ 1.96 billion by 2033, reflecting a CAGR of 4.25% from 2025 to 2033. The market’s expansion is fueled by increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), advancements in dialysis technology, and an aging population requiring renal care.

United States Dialysis Market Outlook

Dialysis is a life-saving therapeutic procedure that substitutes the kidneys’ natural filtration function by removing waste and excess fluids from the blood. In the US, it primarily serves ESRD patients, significantly improving survival rates and quality of life. Nearly half a million Americans rely on dialysis, underscoring its critical role in kidney failure management.

There are two main types of dialysis:

• Hemodialysis: Blood is filtered through a machine, typically performed in a clinic three or more times per week.
• Peritoneal Dialysis: Uses the abdominal lining for filtration, often performed at home, offering flexibility and autonomy to patients.

👉 Want to explore detailed market trends, segment insights, and forecasts? 🔗 Request Free Sample Report

Key Growth Drivers

Rising Incidence of CKD and ESRD

The prevalence of CKD and ESRD is the primary driver of the US dialysis market. Factors such as diabetes, hypertension, obesity, and aging populations contribute to kidney disease growth. According to the CDC, over 14% of US adults (~35.5 million people) are estimated to have CKD. With organ shortages limiting kidney transplantation, dialysis remains the mainstay treatment for most patients. This rising patient base sustains demand for dialysis services, equipment, and consumables, supporting steady market growth.

Technological Advancements in Dialysis

Technological innovation is transforming the dialysis landscape, enhancing patient outcomes and comfort. Advanced hemodialysis machines feature real-time monitoring, sophisticated filtration, and personalized treatment settings. Wearable and portable devices are emerging, promoting home dialysis and reducing reliance on in-center facilities. Telehealth integration optimizes remote monitoring and minimizes hospital visits, while improvements in peritoneal dialysis fluids and biocompatible materials boost safety and efficiency.

Notably, researchers at UNC-Chapel Hill are developing membrane technology that could miniaturize dialysis equipment, potentially revolutionizing home treatment options globally.

Growth of Home Dialysis Programs and Reimbursement Support

Home dialysis adoption is gaining momentum due to government policies and favorable reimbursement programs. The Centers for Medicare & Medicaid Services (CMS) encourages home dialysis to improve patient quality of life and reduce long-term healthcare costs. Home therapies, including peritoneal dialysis and home hemodialysis, offer convenience and autonomy while reducing dependency on dialysis centers.

Reimbursement initiatives like Medicare Part B, covering 80% of home dialysis expenses (training, equipment, and supplies), are fueling adoption. Training programs, supportive technology, and value-based care models further strengthen this growth segment.

Challenges in the United States Dialysis Market

High Treatment Costs and Economic Burden

Dialysis is one of the most expensive long-term care therapies in the US, with recurring costs for machinery, consumables, and professional services. While Medicare covers a significant portion, out-of-pocket expenses remain high, placing financial pressure on patients and providers alike. Facility setup and operating costs also limit accessibility, particularly in medically underserved areas. Balancing affordability, accessibility, and profitability remains a persistent challenge.

Workforce Gaps and Overload on Facilities

Dialysis requires skilled nephrologists, nurses, and technicians. However, the US faces a shortage of trained professionals, leading to high workloads and potential compromises in care quality. Rural areas and underserved populations are particularly affected. Workforce shortages also limit the expansion of home dialysis, as proper training and ongoing patient support are critical. Addressing staffing gaps is essential for sustaining growth and maintaining care standards.

👉 For deeper analysis, detailed segment data, and company insights: 🔗 Request Customization Report

Market Segments

United States Peritoneal Dialysis Market

Peritoneal dialysis is increasingly preferred for its home-based convenience and flexibility. Automated cycler machines and biocompatible dialysis solutions enhance patient safety and comfort. CMS and private insurers support adoption through reimbursement incentives. Challenges include infection risks like peritonitis and the need for patient training. Nevertheless, peritoneal dialysis remains a growing segment due to its patient-centric benefits.

United States Dialysis Services Market

The dialysis services segment, including in-center hemodialysis and home-based therapies, is dominated by players like DaVita and Fresenius. ESRD prevalence guarantees steady demand, with reimbursement policies providing financial stability. Telehealth adoption and patient education initiatives improve treatment compliance. Despite staffing and cost challenges, service providers continue to invest in patient-focused models, making services the largest revenue-generating segment in the US dialysis market.

United States Dialysis Equipment Market

The dialysis equipment market is expanding rapidly, driven by technological advancements and increased treatment needs. High-end hemodialysis machines with real-time monitoring, portable home units, and next-generation peritoneal dialysis cyclers are in high demand. Consumables such as dialyzers, tubing, and catheters remain consistent revenue streams due to repeat purchases. Ongoing R&D investments aim to enhance safety, minimize complications, and improve patient comfort, ensuring continued market growth.

United States Home Dialysis Market

Home dialysis is growing strongly due to patient preference, technological innovation, and policy support. Portable devices, telemonitoring, and simplified equipment improve safety and usability. Initiatives like “Advancing American Kidney Health” accelerate adoption by offering reimbursement incentives. Training and ongoing patient support remain essential, but home dialysis is increasingly becoming a key segment in value-based care models.

Regional Market Insights

California

California represents one of the largest dialysis markets due to its high population, elevated diabetes prevalence, and advanced healthcare infrastructure. Providers maintain extensive networks, and the state is a hub for home dialysis adoption and technological innovation. Policy measures, such as Medicaid expansion, further support growth, although high healthcare costs and rural accessibility challenges persist.

New York

New York’s urban density and high CKD prevalence drive demand for in-center hemodialysis. Home dialysis is increasingly adopted for convenience, supported by Medicare and Medicaid. Despite staffing shortages and high operating costs, technology adoption and patient education programs underpin long-term market expansion.

New Jersey

New Jersey benefits from an aging population and high rates of lifestyle-related kidney diseases. Its proximity to major medical centers enhances access to advanced dialysis technologies. Both in-center and home dialysis are growing, aided by Medicare reimbursement and private insurance support. Challenges include rising healthcare costs and staffing gaps, which providers address through education and home program expansion.

Market Segmentation

By Type:

• Peritoneal Dialysis
• Hemodialysis

By Product & Services:

• Services
• Equipment
• Consumables
• Drugs

By End User:

• Home Dialysis
• In-Center Dialysis

By States:

California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio, Georgia, New Jersey, Washington, North Carolina, Massachusetts, Virginia, Michigan, Maryland, Colorado, Tennessee, Indiana, Arizona, Minnesota, Wisconsin, Missouri, Connecticut, South Carolina, Oregon, Louisiana, Alabama, Kentucky, Rest of US

Key Players

• Asahi Kasei Corporation
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton Dickinson and Company
• DaVita Inc.
• Fresenius Medical Care AG & Co. KGaA
• JMS Co. Ltd.
• Medtronic Plc.

Company analyses include overviews, key persons, recent developments, SWOT, and revenue trends, providing insights into competitive strategies.

Report Details

Base Year: 2024

Historical Period: 2021–2024

Forecast Period: 2025–2033

Market Unit: US$ Billion

Segment Covered: Type, Product & Services, End User, States

Customization Scope: 20% Free Customization

Post-Sale Analyst Support: 1 Year (52 Weeks)

Delivery Format: PDF & Excel (Editable PPT/Word on request)

Customization Services Include:

• Segment-wise market size and analysis
• Additional company profiles (up to 10 free)
• Country-specific and regional reports
• Market entry strategies, trade, and production insights
• Tailored research and analysis

The United States dialysis market is set for steady expansion, supported by rising CKD and ESRD prevalence, technological innovations, home dialysis adoption, and strong reimbursement frameworks. While high costs, workforce shortages, and rural access limitations pose challenges, the sector’s focus on patient-centered care, innovation, and policy support ensures robust long-term growth.

Note: If you need details, data, or insights not covered in this report, we are glad to assist. Through our customization service, we will collect and deliver the information you require, tailored to your specific needs. Share your requirements with us, and we will update the report to align with your expectations.